Oral question asked in the House of Commons, by Christopher Fraser (Conservative). It was answered on Tuesday, 30 March 2010 on behalf of the Department of Health.
Medicines (Parallel Exports)
- Question
- What estimate has been made of the amount of potential research and development money that is lost to British firms as a result of parallel trading?
- Answer
-
Research and development money is only part of the issue. The key issue is that patients are sometimes not getting the medicines that they need. That is what parallel exporting is all about; it is not so much about the research and development that takes place in a number of centres. When patients go to the chemist, they want to know that the medicines they need will be there.
Secondary information
- Type
- Oral question
- Reference
- 508 c618
- Session
- 2009-10
- Oral question type
- 1st Supplementary
- Chamber / Committee
- House of Commons chamber
- Subjects
- Drugs NHS
- Link
- View this Oral question on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-01 15:10:12 +0000
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1509690/-question
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1509690/-question
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1509690/-question